Related Experiment Video

Updated: Aug 4, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

MKP-3 has essential roles as a negative regulator of the Ras/mitogen-activated protein kinase pathway during

Myungjin Kim1, Guang-Ho Cha, Sunhong Kim

  • 1National Creative Research Initiatives Center for Cell Growth Regulation and Department of Biological Sciences, Korea Advanced Institute of Science and Technology, 373-1 Kusong-Dong, Yusong, Taejon 305-701, Republic of Korea.

Molecular and Cellular Biology
|January 1, 2004
PubMed

Insights

Mitogen-activated protein kinase 3 (MKP-3) regulates cell development by controlling the Ras/ERK pathway in Drosophila. This study reveals DMKP-3

Area of Science:

  • Developmental Biology
  • Cell Signaling
  • Molecular Genetics

Background:

  • Mitogen-activated protein kinase (MAPK) phosphatase 3 (MKP-3) is a negative regulator of the Ras/extracellular signal-regulated kinase (ERK)-MAPK pathway.
  • This pathway is crucial for cell fate determination and proliferation during development.
  • The specific in vivo roles and regulatory mechanisms of MKP-3 in Ras/Drosophila ERK (DERK) signaling were previously undetermined.

Purpose of the Study:

  • To elucidate the physiological roles of Drosophila MKP-3 (DMKP-3) in vivo.
  • To investigate the mechanism by which DMKP-3 regulates the Ras/DERK signaling pathway.
  • To provide direct evidence for DMKP-3's role in Drosophila development.

Main Methods:

  • Investigated DMKP-3 function through overexpression, hypomorphic mutants, and null mutants in Drosophila.
  • Analyzed phenotypes including photoreceptor cell number, wing vein differentiation, embryonic lethality, and oogenesis.
  • Confirmed functional interaction via genetic interaction studies with the Ras/DERK pathway components.

Main Results:

  • DMKP-3 suppresses the Ras/DERK pathway by binding to DERK via its N-terminal ERK-binding domain.
  • Overexpression of DMKP-3 led to reduced photoreceptor cells and inhibited wing vein differentiation.
  • DMKP-3 loss-of-function mutants displayed extra photoreceptor cells and wing veins, with null mutants showing embryonic lethality and oogenesis defects.
  • Phenotypes mirrored those of DERK/rl gain-of-function mutants, confirming DMKP-3's regulatory role.

Conclusions:

  • Drosophila MKP-3 (DMKP-3) is essential for regulating cell differentiation, proliferation, and gene expression.
  • DMKP-3 directly suppresses DERK signaling activity through physical interaction.
  • DMKP-3 plays an indispensable role in Drosophila development by modulating DERK signaling.

More Related Videos

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...